Westlake Chemical Partners Hits 52-Week Low at $21.08 Amid Declining Performance

Westlake Chemical Partners LP has reached a new 52-week low, trading at USD 21.08 as of September 19, 2025. This marks a significant decline for the specialty chemicals company, which has seen its stock price decrease by 6.79% over the past year, contrasting sharply with the S&P 500's performance of 16.64% during the same period.
The company, with a market capitalization of USD 774 million, operates within the microcap segment of the specialty chemicals industry. Its price-to-earnings (P/E) ratio stands at 2.00, indicating a potentially attractive valuation compared to industry norms. However, Westlake Chemical Partners has faced challenges, including a decline in operating profit at an annual rate of -1.43% over the last five years.

Despite a high return on equity of 63.29% and a manageable debt-to-equity ratio of 0.72, the company has reported negative results recently, including a significant drop in net profit and rising raw material costs. The stock's performance has consistently lagged behind the S&P 500, highlighting ongoing difficulties in achieving long-term growth.